Table 5.
Descriptive Data for Dependent Variables at Dose Levels.
Means (M) and Standard Deviations (SD) for Hyperactivity, Inattention, Impulsivity and Weighed Core Symptoms (WCS) Scale with Regard to Dose Levels. Treatment Consisted of a Modified-Release Formulation of MPH in 10 Adults (6 Females) with ADHD
| WCS | Hyperactivity | Inattention | Impulsivity | |||||
|---|---|---|---|---|---|---|---|---|
| M | SD | M | SD | M | SD | M | SD | |
| Baseline | 31.00* | 26.85 | 60.30* | 25.90 | 34.30* | 10.86 | 62.43* | 25.38 |
| 18/27 mg | 38.75¤ | 31.82 | 61.57 | 22.22 | 43.04 | 16.35 | 65.71 | 15.54 |
| 36 mg | 55.00¤ | 28.38 | 68.96 | 11.71 | 52.41 | 23.71 | 74.71 | 14.58 |
| 54/72 mg | 77.14 | 24.98 | 73.77 | 15.41 | 61.48 | 11.64 | 87.14 | 5.15 |
| Follow-up | 65.00 69.00* |
33.32 22.34 |
75.62 73.88* |
18.56 11.86 |
52.37 55.19* |
30.64 17.37 |
86.43 81.29* |
6.31 10.62 |
Note. Higher values indicate lower levels of ADHD symptoms; The asterisk (*) indicates significant differences between baseline and follow-up; The square (¤) indicates significant differences from the tabulated value above.